Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers

Abstract

Programmed Death Ligand 1 (PD-L1) positivity rates differ between different metastatic sites and the primary tumor. Understanding PD-L1 expression characteristics could guide biopsy procedures and motivate research to better understand...